Jagsonpal PharmaceuticalsJAGSNPHARM 
$4.78-2.58%24h
-2.58%24h
Global rank20036
Market cap$125.13M
Change 7d5.53%
YTD Performance2.44%
SP500 benchmarkUnderperform
P/E0.47
P/S4.43
Revenue$28.22M
Earnings$3.19M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Jagsonpal Pharmaceuticals (JAGSNPHARM)
Jagsonpal Pharmaceuticals has an EPS of $10.2. In 2022, the company made an earnings per share (EPS) of $7.2. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for JAGSNPHARM
-
Value:-
EPS history for Jagsonpal Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $10.20 | 41.67% |
| 2022 | $7.20 | 10.60% |
| 2021 | $6.51 | 117.00% |
| 2020 | $3.00 | - |
View the highest EPS stocks
